title: [Should benefit-risk ratio of the intramuscular vitamin K be reevaluated in newborn infants?].
authors.affiliation: Service de pharmacologie clinique, hôpital Bretonneau, Tours, France.
authors.forename: E
authors.initials: E
authors.lastname: Autret
authors.forename: A P
authors.initials: AP
authors.lastname: Jonville-Bera
mesh_terms: D000367:Age Factors; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D009369:Neoplasms / Q000139:chemically induced; D016017:Odds Ratio; D018570:Risk Assessment; D014812:Vitamin K / Q000008:administration & dosage* / Q000009:adverse effects; D006475:Vitamin K Deficiency Bleeding / Q000139:chemically induced
chemical_list: D014812:Vitamin K
vernacular_title: Le rapport bénéfice/risque de la vitamine K intramusculaire doit-il être réévalué chez le nouveau-né?